Amylyx was started in 2013 by two Brown University students who had an ambitious goal: to improve the lives of people with neurodegenerative diseases by addressing the root cause. Their research and close collaboration with the ALS community ultimately resulted in our first commercial product, which is now approved in the U.S. and conditionally approved in Canada.

At Amylyx, we’re bringing together talented people like you who are guided by our values to be Audacious, Curious, Authentic, Engaging and Accountable in the fight against neurodegenerative diseases like, ALS, Alzheimer’s disease, Wolfram Syndrome and others.

Rediscover your purpose and reimagine your career at a company whose founders, mission, and culture are unlike any other in life sciences—in all the best ways.

Recent milestones include:

  • The U.S. Food and Drug Administration (FDA) approved RELYVRIO™ in September of 2022
  • Health Canada approved ALBRIOZA™ with conditions in Canada in June of 2022
  • AMX0035 is currently under review with the European Medicines Agency
  • 280 employees globally, with headquarters in Cambridge, MA, US and Amsterdam, the Netherlands -- and growing strong!


The Head, Global Safety and Pharmacovigilance will lead the strategic management, planning, operations and execution of the Global Safety and Pharmacovigilance function for Amylyx products.   This person will be responsible for the development and compliance of the global pharmacovigilance system to ensure patient safety, full regulatory compliance, and timely flow of drug safety information from all sources, pre- and post-marketing, to clinical teams and senior management. You will work jointly with Clinical Development and Regulatory and provide oversight of drug safety for products in clinical development.

We are open to candidates in the United States, Canada, and Europe.


  • Manage and lead the Safety and Pharmacovigilance department including oversight, operations and continuous growth.
    • Provide direction and leadership regarding safety vendors selection and management. Accountable for effective oversight of outsourced operational activities, measuring vendor performance through Key Performance Indicators/Metrics according to Amylyx standards and contracted Service Level Agreements(s). Recognize and escalate significant issues to ensure continuity of business objectives
    • Oversee the appropriate management of safety data exchange agreements, safety management plans, and other operating procedures with business partners as required. Accountable for partnering with vendors for resolution of safety operational issues and questions, identifying vendor training needs and opportunities for improvement, and ensuring implementation in collaboration with Amylyx stakeholders.
    • Collaborate with Amylyx team members on the development and implementation of safety and pharmacovigilance procedures (including SOPs, CAPAs, and third-party agreements) and documents used to provide training in Pharmacovigilance across the Company
    • Ensure inspection readiness for FDA or other regulatory agencies inspection activities related to safety and pharmacovigilance. Maintain safety inspection preparedness and ensure compliance with GCP and all applicable regulations. Support interactions and report, respond and resolve safety questions from the FDA, EMEA, and other regulatory authorities, and respond to regulatory agency audits.
    • Identify opportunities for process efficiencies and participate in process improvement initiatives
  • Ensure compliance with health authority regulations in all aspects of case processing and reporting.
    • Execute EU Pharmacovigilance requirements including QPPV oversight.
    • Work with regulatory affairs to maintain and update regulatory reporting rules
    • Track compliance of expedited safety reports
    • Manage all signal detection and safety reporting activities, in partnership with external vendors, from all sources (spontaneous, literature, product/patient support programs, market research programs, clinical trials, medical information, call centers, health authorities, post marketing commitment studies, etc.) according to Amylyx’s SOPs and global regulations and guidelines.
    • Manage aggregate report production and ensure compliance with timely reporting. Content owner /author of relevant sections of investigational and marketed product pharmacovigilance related documents (e.g., DSUR, PBRER). Oversee, prepare, and review scheduled periodic/annual reports and INDs, IMPDs per local regulations.
  • Lead Safety Review Meetings for company product(s). Provide strategic or operational input on project teams and interact with senior management to report project updates.
    • Collaborate with pre-clinical and clinical development to better assess and understand drug safety profiles Develop responses to health authorities regarding safety and pharmacovigilance.
  • Oversee Safety Operations and reporting during clinical trials.
    • Partner with clinical operations, regulatory affairs, clinical research organizations (CRO) and data management groups regarding safety data collection and data reconciliation for all clinical trials.  Point of contact for Safety risks identified by Medical Monitor.  Provide medical/clinical review of applicable Case Safety reports.  Oversee the resolution of safety queries.
    • Contribute to Investigator’s Brochure (IBs); provide standardized safety language where required for informed consent forms (ICFs), study protocols, and other clinical documents as required.
    • Plan and implement database safety reconciliations in collaboration with data management, compliance and CROs as required. 


  • Minimum of 15+ years Safety / Pharmacovigilance experience in pre- and post- marketing environments with increasing responsibility of managerial oversight.
  • MD or PharmD degree preferred. Board certification and/or experience in neurology indication(s) a plus.
  • Excellent leadership qualities such as strategic thinking, people and resource management expertise.
  • Demonstrated technical, administrative, and project management capabilities including: thorough understanding of Individual Case Safety Reports (ICSR) processing operations required, global pharmacovigilance regulatory environment with working knowledge of US and EU regulations, ICH guidelines, and a working understanding of common drug safety databases (e.g., Veeva).
  • Effective project management skills with a demonstrated ability to provide critical and timely insight, and analytical problem-solving skills with a broad perspective.
  • Ability to communicate complex clinical issues in a scientifically sound and understandable way.
  • Experience working with all levels of management and consulting with key functions to influence greater outcomes.
  • Skilled at negotiating with business partners and management and influencing senior level leaders regarding matters of significance to the department or, more broadly, the organization. Adept at creating and communicating a clear vision among team members effectively aligning resources to achieve goals.


To stay connected with us, follow Amylyx Pharmaceuticals on LinkedIn.

To return to our website please click here.

Amylyx is proud to be an Equal Employment Opportunity employer. We do not discriminate based upon race, religion, color, national origin, gender (including pregnancy, childbirth, or related medical matters), sexual orientation, gender identity, gender expression, age, status as a protected veteran, status as an individual with a disability, or other applicable legally protected characteristics. Accommodations are available for candidates who require them in our selection process. If you need an accommodation, please let your Amylyx Talent Acquisition contact know.

Apply for this Job

* Required

resume chosen  
(File types: pdf, doc, docx, txt, rtf)
cover_letter chosen  
(File types: pdf, doc, docx, txt, rtf)

Voluntary Self-Identification

For government reporting purposes, we ask candidates to respond to the below self-identification survey. Completion of the form is entirely voluntary. Whatever your decision, it will not be considered in the hiring process or thereafter. Any information that you do provide will be recorded and maintained in a confidential file.

As set forth in Amylyx’s Equal Employment Opportunity policy, we do not discriminate on the basis of any protected group status under any applicable law.

Race & Ethnicity Definitions

If you believe you belong to any of the categories of protected veterans listed below, please indicate by making the appropriate selection. As a government contractor subject to the Vietnam Era Veterans Readjustment Assistance Act (VEVRAA), we request this information in order to measure the effectiveness of the outreach and positive recruitment efforts we undertake pursuant to VEVRAA. Classification of protected categories is as follows:

A "disabled veteran" is one of the following: a veteran of the U.S. military, ground, naval or air service who is entitled to compensation (or who but for the receipt of military retired pay would be entitled to compensation) under laws administered by the Secretary of Veterans Affairs; or a person who was discharged or released from active duty because of a service-connected disability.

A "recently separated veteran" means any veteran during the three-year period beginning on the date of such veteran's discharge or release from active duty in the U.S. military, ground, naval, or air service.

An "active duty wartime or campaign badge veteran" means a veteran who served on active duty in the U.S. military, ground, naval or air service during a war, or in a campaign or expedition for which a campaign badge has been authorized under the laws administered by the Department of Defense.

An "Armed forces service medal veteran" means a veteran who, while serving on active duty in the U.S. military, ground, naval or air service, participated in a United States military operation for which an Armed Forces service medal was awarded pursuant to Executive Order 12985.

Form CC-305

OMB Control Number 1250-0005

Expires 05/31/2023

Voluntary Self-Identification of Disability

Why are you being asked to complete this form?

We are a federal contractor or subcontractor required by law to provide equal employment opportunity to qualified people with disabilities. We are also required to measure our progress toward having at least 7% of our workforce be individuals with disabilities. To do this, we must ask applicants and employees if they have a disability or have ever had a disability. Because a person may become disabled at any time, we ask all of our employees to update their information at least every five years.

Identifying yourself as an individual with a disability is voluntary, and we hope that you will choose to do so. Your answer will be maintained confidentially and not be seen by selecting officials or anyone else involved in making personnel decisions. Completing the form will not negatively impact you in any way, regardless of whether you have self-identified in the past. For more information about this form or the equal employment obligations of federal contractors under Section 503 of the Rehabilitation Act, visit the U.S. Department of Labor’s Office of Federal Contract Compliance Programs (OFCCP) website at

How do you know if you have a disability?

You are considered to have a disability if you have a physical or mental impairment or medical condition that substantially limits a major life activity, or if you have a history or record of such an impairment or medical condition.

Disabilities include, but are not limited to:

  • Autism
  • Autoimmune disorder, for example, lupus, fibromyalgia, rheumatoid arthritis, or HIV/AIDS
  • Blind or low vision
  • Cancer
  • Cardiovascular or heart disease
  • Celiac disease
  • Cerebral palsy
  • Deaf or hard of hearing
  • Depression or anxiety
  • Diabetes
  • Epilepsy
  • Gastrointestinal disorders, for example, Crohn's Disease, or irritable bowel syndrome
  • Intellectual disability
  • Missing limbs or partially missing limbs
  • Nervous system condition for example, migraine headaches, Parkinson’s disease, or Multiple sclerosis (MS)
  • Psychiatric condition, for example, bipolar disorder, schizophrenia, PTSD, or major depression

PUBLIC BURDEN STATEMENT: According to the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless such collection displays a valid OMB control number. This survey should take about 5 minutes to complete.

Please reach out to our support team via our help center.